
               
               
               7 DRUG INTERACTIONS
               
                  
                     

                  
               
               
               
                  
                     
                        
                           Use with caution in patients receiving Class I antiarrhythmic drugs (such as tocainide and mexiletine) since the systemic toxic effects are thought to be additive and potentially synergistic with lidocaine and tetracaine. (7.1)
                           When used concomitantly with other products containing local anesthetic agents, amount absorbed from all formulations should be considered since systemic toxic effects are thought to be additive and potentially synergistic with lidocaine and tetracaine. (7.2)
                        
                     
                  
               
               
                  
                     
                     
                     7.1  Antiarrhythmic Drugs
                     
                        PLIAGLIS Cream should be used with caution in patients receiving Class I antiarrhythmic drugs (such as tocainide and mexiletine) since the systemic toxic effects are thought to be additive and potentially synergistic with lidocaine and tetracaine.
                     
                  
               
               
                  
                     
                     
                     7.2  Local Anesthetics
                     
                        When PLIAGLIS Cream is used concomitantly with other products containing local anesthetic agents, the amount absorbed from all formulations should be considered since the systemic toxic effects are thought to be additive and potentially synergistic with lidocaine and tetracaine.
                     
                  
               
            
         